Company Profile

Xi'an Manareco New Materials Co.,Ltd
Year Established : 2001
Total Assets(USD) : More than 99,999,999
Total Number of Staff : more than 1000
Main Competitive Advantages : Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
  • Contact Person :
  • Fax:

Xi'an Manareco New Materials Co., Ltd. was established in 1999, whose shares are jointly held by Beijing Manareco Holding Corp. Ltd, CapitalEdge Investment Management Co., Ltd., Eastern Ocean (Wuhu) Equity Investment Fund (LLP),Shanghai Pivot Capital Co., Ltd. and other well-known investment institutions as well as internal middle and senior managers. It is a high-tech company which focuses on R&D, manufacture and marketing of organic new materials, involving in liquid crystal singles, OLED materials and pharmaceutical intermediates, which will be applied to LC mixtures, OLED final materials, and APIs. Also, the final application areas of our products include TFT-LCD, OLED and pharmaceutical preparation.

There are nearly 1,400 full-time employees in Xi’an Manareco, and 50% of which have bachelor's degree. The company consists of administrative and R&D base in Xi’an headquarters and two production bases in Weinan and Pucheng, which can provide one-stop service from lab work, pilot to mass production. It has more than 30 patents and 30 production lines. Over 2,000 display material chemicals have been developed, and self-developed synthetic route has exceeded 3,500.

As a representative enterprise in the field of liquid crystal display materials, Xi'an Manareco has established strategic partnerships with major liquid crystal manufacturers around the world and occupied the high-end market of liquid crystal singles for a long time. Also, as one of the leading companies in OLED material, the company stands in the leading position of domestic OLED material development, and it has set up cooperation relationship with international leading companies who occupy almost 70% market share for global OLED final materials, standing the important position in their supply chains. Furthermore, in pharmaceutical area, owing to the outstanding R&D capability, Xi’an Manareco has became an important supplier for international drug giants. 

Facing the great strategic opportunity of LCD material market transferring from abroad to home and OLED material industry rising rapidly, the company has deepened delicacy management, improved management level and risk prevention ability, and reinforced endogenous driving force for sustainable development. With the management idea of "Openness, Integration, Innovation, Development", the company will actively explore new products, new customers and new fields. By virtue of strong R&D and innovation capabilities and industrialization advantage, Xi'an Manareco is committed to becoming an excellent enterprise in the high-end fine chemicals industry.

PharmaSources Customer Service